Connect with us

News

COVID-19: United States Halts Use of Johnson & Johnson Vaccine

Published

on

COVID-19

The U.S Federal Health Agencies on Tuesday, April 13, called for the suspension of the use of the Johnson & Johnson COVID-19 vaccine.

U.S health agencies are asking states to temporarily halt using Johnson & Johnson COVID-19 vaccine after recipients developed blood-clotting disorder.

Six people who developed a rare disorder involving blood clots are the latest cases of the after-effects of the Johnson & Johnson COVID-19 vaccine.

The rare disorder has already left one woman dead and another in critical condition in Nebraska.

Getty Images Reuters reports all six cases involved women between the ages of 18 and 48. The symptoms occurred 6 to 13 days after they took Johnson & Johnson’s vaccine.

In a report, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) in a statement recommended a pause out of caution. Johnson & Johnson on its part said there has been no clear causal relationship between these cases and the shot made by its Janssen unit.

COVID-19: United States calls for pause to Johnson & Johnson vaccine after blood clot kills 1

Share

Facebook

Trending

Copyright © 2019, February13 Media